TORRENT PHARMACEUTICALS LTD. - 500420 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Conference call with Analysts / investors on financial results for the quarter ended 30th June, 2023 attached.
Buy Torrent Pharmaceuticals; target of Rs 2250: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 2250 in its research report dated August 08, 2023. TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates TORRENT PHARMACEUTICALS LTD. - 500420 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Declaration of voting result and Scrutinizer Report TORRENT PHARMACEUTICALS LTD. - 500420 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Declaration of voting result
Torrent Pharmaceuticals Results Earnings Call for Q1FY24
Conference Call with Torrent Pharmaceuticals Management and Analysts on Q1FY24 Performance and Outlook. Listen to the full earnings transcript. TORRENT PHARMACEUTICALS LTD. - 500420 - Audio Recording Of Conference Call With Analysts / Investors On Financial Results For The Quarter Ended 30Th June, 2023
Audio Recording of Conference call with Analysts /Investors on Financial Results for the quarter ended 30th June, 2023 is attached TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Nikhil Khattau as an Independent Director of the Company